Skip to content
Medical Health Aged Care

Music can stave off dementia by up to 40 per cent, Monash study finds

Monash University 2 mins read

Listening to music when you are over 70 years of age has been linked to a 39 per cent      reduction in the risk of dementia, according to a Monash University-led study of over 10,800 older people.

The study, led by Monash honours student Emma Jaffa, and Professor Joanne Ryan, looked at the benefits of listening to music or playing music in people aged over 70, finding that always listening to music compared with never/rarely/sometimes listening to music was associated with a 39 per cent decreased risk of dementia. While playing an instrument was associated with a 35 per cent reduction in dementia risk.

This study used data from the ASPirin in Reducing Events in the Elderly (ASPREE) study, and the ASPREE Longitudinal Study of Older Persons (ALSOP) substudy and was published in the International Journal of Geriatric Psychiatry.

The study found that always listening to music was associated with the greatest reduction in dementia risk, with a 39 per cent lower incidence of dementia and 17 per cent lower incidence of cognitive impairment, as well as higher scores in overall cognition and episodic memory (used when recalling everyday events). While regularly engaging in both music listening and playing was associated with a 33 per cent decreased risk of dementia and 22 per cent      decreased risk of cognitive impairment.

According to Ms Jaffa     , the findings of the study “suggests music activities may be an accessible strategy for maintaining cognitive health in older adults, though causation cannot be established,” she said.

Population ageing has become a global public health concern due to advances in medicine and technology extending human lifespans, and this longer life expectancy has also meant an increase in the prevalence of agerelated diseases, including cognitive decline and dementia.

With no cure currently available for dementia, the importance of identifying strategies to help prevent or delay onset of the disease is critical,” senior author Professor Ryan said.

“Evidence suggests that brain ageing is not just based on age and genetics but can be influenced by one's own environmental and lifestyle choices. Our study suggests that lifestyle-based interventions, such as listening and/or playing music can promote cognitive health.”

Read the full paper in the International Journal of Geriatric Psychiatry: What is the association between music-related leisure activities and dementia risk? A cohort study. DOI: 10.1002/gps.70163

 

More from this category

  • Medical Health Aged Care, Mental Health
  • 31/01/2026
  • 06:37
MindEar

Help your brain filter out tinnitus and get your life back this Tinnitus Awareness Week

Experts available to talk about tinnitus, their family experience, and how new tools can make a difference for millions of people - in Sydney, Australia, and in Bristol and Newcastle (UK) A free trial of the latest evidence-based therapies is available for Tinnitus Awareness Week. The seven-day challenge incorporates the latest research from Newcastle University in the UK along with research from Auckland University, the Ear Institute at University College London and Leeds Trinity University. Many people living with tinnitus are still told that “nothing can be done” but clinicians following the latest research say that is bad advice which…

  • Contains:
  • Medical Health Aged Care
  • 31/01/2026
  • 00:10
Kyowa Kirin

Kyowa Kirin to Regain Control of Rocatinlimab Development and Commercialization Program, Demonstrating Strong Commitment to Address High Unmet Medical Need in Atopic Dermatitis

Kyowa Kirin affirms commitment to developing rocatinlimab as a life-changing differentiated asset with significant market potential.Rocatinlimab’s novel approach as an investigational T-cell rebalancing therapy directly targeting the OX40 receptor expressed on pathogenic T-cells shows potential to deliver long-term disease control in patients with moderate-to-severe atopic dermatitis (msAD).Regulatory submission is planned in the first half of 2026.TOKYO and PRINCETON, N.J., Jan. 30, 2026 (GLOBE NEWSWIRE) -- Kyowa Kirin Co., Ltd. (TSE:4151, Kyowa Kirin), a Japan-based global specialty pharmaceutical company, today announced the termination of the current rocatinlimab development and commercialization collaboration with Amgen. Kyowa Kirin will regain control of the global…

  • Medical Health Aged Care
  • 30/01/2026
  • 17:12
Galderma

Galderma Tackles Menopause-related Skin Changes With Global Survey and Clinical Trial Inclusivity

Results from a global survey of over 4,300 women across five continents presented at IMCAS 2026 reveal a knowledge gap on the impact of…

  • Contains:

Media Outreach made fast, easy, simple.

Feature your press release on Medianet's News Hub every time you distribute with Medianet. Pay per release or save with a subscription.